scorecardresearch
Add as a preferred source on Google
Wednesday, November 12, 2025
TopicAstraZeneca

Topic: AstraZeneca

AstraZeneca vaccine has no adverse impact on pregnancy or fertility, study in Lancet says

In the study spanning UK, Brazil and South Africa, the rate of miscarriage was roughly the same between vaccine and placebo groups, & no still births or neonatal deaths were recorded.

AstraZeneca antibody cocktail prevents Covid in high-risk groups, study finds

AstraZeneca said it is preparing to submit the data to regulators for potential emergency-use authorisation. Its findings may also salvage a deal with the US to purchase the drug.

AstraZeneca to apply for Covid vaccine approval in US later this year

The vaccine, which is being produced as Covishield in India, is approved for use by the UK and European medicines regulators but is pending USFDA application.

Animal trials suggest intranasal version of AstraZeneca shot may prevent Covid transmission

Currently tested on animals, researchers now intend to test the effectiveness of intranasal vaccines, in both preventing infection and lowering viral shedding in humans.

Countries using AstraZeneca, Chinese vaccines are considering boosters for Delta protection

Growing concern that Covid-19 vaccines being deployed across much of the developing world aren’t capable of thwarting the delta variant is prompting some countries...

Mixing Astra and Pfizer shots creates strong immune response, Oxford study shows

A mixed schedule of the Pfizer shot followed by Astra vaccine, and vice versa, resulted in high concentrations of antibodies against Covid when given 4 weeks apart, researchers said.

AstraZeneca vaccine could be less effective against Delta variant: Scotland study in Lancet

The study by Scotland researchers found that the risk of hospital admission was approximately double in Covid patients with the Delta variant, compared to those with the Alpha strain.

AstraZeneca vaccine’s chief investigator backs 12-16 week Covishield dose gap in India

Professor Andrew Pollard said that the level of protection provided by one dose of the vaccine significantly increases in the second and third months after the jab.

Pfizer, AstraZeneca vaccines provide ‘good protection’ against Delta variant: Lancet study

The study finds Pfizer's Covid vaccine offers 79 per cent protection and the AstraZeneca vaccine, known as Covishield in India, secures 60 per cent protection against Covid strain.

AstraZeneca vaccine linked to slightly higher risk of low platelet count, study says

The study, published in the journal Nature Medicine, says Oxford-AstraZeneca vaccine carries a slightly increased risk of a drop in platelet count and blood clots in arteries.

On Camera

Air purifiers are the new water filters. Delhi has quietly accepted a crisis

The affluent in Delhi, armed with airtight windows, multiple purifiers, and humidifiers, have normalised a way of life that once seemed dystopian.

India’s factory data may get reality check in MoSPI’s new IIP plan, defunct factories to be dropped

MoSPI proposes to remove closed factories from IIP sample, aiming for truer picture of India’s industrial health in upcoming 2022–23 base series. Plan open to public feedback until 25 November.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.